Question 1: The benefits of participating in a national or international incident learning system include:
|
Reference: | ASTRO RO-ILS web site: https://www.astro.org/roils/
SAFRON web site: https://rpop.iaea.org/RPOP/RPoP/Modules/login/safron-register.htm ROSIS web site: http://www.rosis.info/index.php
|
Choice A: | Promoting safety culture. |
Choice B: | Receiving Reports on incidents from a larger community. |
Choice C: | Analyzing local safety improvement efforts. |
Choice D: | Gaining access to safety related articles and teaching. |
Choice E: | All of the above |
Question 2: The new MPPG 5 is intended to replace the old Task Group #53 report.
|
Reference: | Fraass, B. et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med. Phys. 25, 1773–1829 (1998).
Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015).
|
Choice A: | True. |
Choice B: | False. |
Question 3: What does the MPPG #5 recommend for gamma analysis criteria for IMRT/VMAT TPS validation?
|
Reference: | Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015).
Opp, D, B E Nelms, G Zhang, C Stevens, and V Feygelman. "Validation of measurement-guided 3D VMAT dose reconstruction on a heterogeneous anthropomorphic phantom." J. Appl. Clin. Med. Phys. 14, no. 4 (Jul 2013): 4154
|
Choice A: | 1%/1mm. |
Choice B: | 2%/2 mm |
Choice C: | 3%/3 mm |
Choice D: | 5%/5 mm |
Choice E: | No recommendation is given. User should reference current accrediting criteria and published literature. |
Question 4: The MPPG #5 recommends which of the following for IMRT/VMAT validation?
|
Reference: | Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015).
|
Choice A: | Small PDD and OF measurements not used in commissioning. |
Choice B: | AAPM TG 119 tests. |
Choice C: | DQA on representative clinical IMRT/VMAT cases. |
Choice D: | External review. |
Choice E: | All of the above. |
Question 5: The upcoming TG100 report predominantly relies on:
|
Reference: | M.S. Huq, B.A. Fraass, P.B. Dunscombe, J.P. Gibbons, G.S. Ibbott, P.M. Medin, A. Mundt, S. Mutic,
J.A. Palta, B.R. Thomadsen, J.F. Williamson, E.D. Yorke. A method for evaluating quality assurance needs in radiation therapy.
Int J Radiat Oncol Biol Phys, 2008; 71(1 Suppl), S170-3.
|
Choice A: | SPC |
Choice B: | ILS |
Choice C: | QC/QA |
Choice D: | FMEA |
Choice E: | RPC |
Question 6: RPC tolerance for IMRT head and neck phantom irradiation is:
|
Reference: | Molineu et al, Credentialing results from IMRT irradiations of an anthropomorphic head and neck, Med Phys, 40, 2013. |
Choice A: | 2%/2mm |
Choice B: | 3%/3mm |
Choice C: | 7%/4mm |
Choice D: | 2% |
Choice E: | 2mm |